SCH 58261, a selective adenosine A2A receptor antagonist with potential antiparkinsonian properties: J. Wardas,J. Konieczny,E. Lorenc-Koci,M. Pietraszek,M. Zapała. Institute of Pharmacology,Polish Academy of Sciences, 12 Smetna St., 31–343 Kraków,Poland |